New Diamond-Tipped catheter takes on heart rhythm disorder

NCT ID NCT06028919

Completed Disease control Sponsor: University Hospitals Coventry and Warwickshire NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tested a new ablation catheter (DiamondTemp) against the current standard (Tacticath/Tactiflex) for treating ventricular tachycardia (VT), a life-threatening fast heart rhythm. 61 adults with VT who needed ablation took part. The goal was to see if the new catheter is as safe and effective at reducing VT episodes over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DiamondTemp ablation catheter (device) vs Tacticath/Tactiflex ablation catheter (device)
What this could lead to: If the DiamondTemp catheter works as well as the standard one, it could offer doctors another safe and effective tool to treat VT and reduce the need for painful shocks from defibrillators.
What could go wrong: This is a small, completed trial with only 61 people, so results may not apply to everyone. The new catheter might not be as effective or safe as the current standard, and any ablation procedure carries risks like bleeding or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR TACHYCARDIA

Contacts and locations

Locations

University Hospital Coventry and Warwickshire NHS Trust

Coventry, West Midlands, CV22DX, United Kingdom
University Hospitals Sussex NHS Foundation Trust

Brighton, BN2 1ES, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.